+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Primary Progressive Aphasia - Pipeline Insight, 2025 - Product Thumbnail Image

Primary Progressive Aphasia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Lambert-Eaton Myasthenic Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Lambert-Eaton Myasthenic Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pyoderma Gangrenosum (PG) - Pipeline Insight, 2025 - Product Thumbnail Image

Pyoderma Gangrenosum (PG) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pseudoxanthoma Elasticum - Pipeline Insight, 2025 - Product Thumbnail Image

Pseudoxanthoma Elasticum - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Phosphoglucomutase (PGM 1) Deficiency - Pipeline Insight, 2025 - Product Thumbnail Image

Phosphoglucomutase (PGM 1) Deficiency - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sialorrhea - Pipeline Insight, 2025 - Product Thumbnail Image

Sialorrhea - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Hallux Valgus - Pipeline Insight, 2025 - Product Thumbnail Image

Hallux Valgus - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Persistent Pulmonary Hypertension Of The Newborn - Pipeline Insight, 2025 - Product Thumbnail Image

Persistent Pulmonary Hypertension Of The Newborn - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acid Sphingomyelinase Deficiency (ASMD) - Pipeline Insight, 2025 - Product Thumbnail Image

Acid Sphingomyelinase Deficiency (ASMD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alopecia Areata- Pipeline Insight, 2025 - Product Thumbnail Image

Alopecia Areata- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Acquired Blepharoptosis - Pipeline Insight, 2025 - Product Thumbnail Image

Acquired Blepharoptosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acute Unilateral Vestibulopathy (AUV) - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Unilateral Vestibulopathy (AUV) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mucopolysaccharidosis III - Pipeline Insight, 2025 - Product Thumbnail Image

Mucopolysaccharidosis III - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Herpes Labialis - Pipeline Insight, 2025 - Product Thumbnail Image

Herpes Labialis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
5-HT2A Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT2A Agonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
CRF1 Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

CRF1 Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
5-HT1A Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT1A Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
5-HT2C Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT2C Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Platelet Derived Growth Factor Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Platelet Derived Growth Factor Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cholesterol Absorption Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cholesterol Absorption Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more